
Tanya Dougherty, PharmD, BCPS
Advertisement
Articles by Tanya Dougherty, PharmD, BCPS
Advertisement
Latest Updated Articles
Efficacy of Oral Semaglutide: Overview of the PIONEER Clinical Trial Program and Implications for Managed CarePublished: December 13th 2020 | Updated:
Type 2 Diabetes in the US Managed Care Setting: The Burden of Disease and Rationale for an Oral Glucagon-like Peptide-1 Receptor AgonistPublished: December 14th 2020 | Updated:
The Importance of Patient-Reported Outcomes in Type 2 Diabetes: Insight From the PIONEER Program With Oral SemaglutidePublished: December 11th 2020 | Updated:
Cardiovascular Outcomes, Safety, and Tolerability With Oral Semaglutide: Insights for Managed CarePublished: December 12th 2020 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD
4
Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making
5



